Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U74999MH2017PTC295476 Incorporated 29 May 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.83 Cr
▲ 42.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹71.45 Lakh
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
41
Latest available

About Avery Pharmaceuticals Private Limited

Data last updated: 22 December 2025

Avery Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Arrow Greentech Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 29 May 2017, the company has been in operation for over 9 years.

Registered with ROC Mumbai under CIN U74999MH2017PTC295476.

Capital: an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹71.45 Lakh. It is led by directors Shilpan Pravin Patel and Neil Shilpan Patel.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 42% compared to the previous year.

The company has a workforce of approximately 41 employees as per the latest available data. It operates as a subsidiary of Arrow Greentech Limited.

The company is associated with 1 brand - Avery Pharmaceuticals. As per MCA filings, the company has open charges of ₹3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website averypharma.co.in.

Company Details of Avery Pharmaceuticals Private Limited
CIN U74999MH2017PTC295476
Registration Number 295476
Incorporation Date 29 May 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Arrow Greentech Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Drug Formulation & Development
Company report
Avery Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Avery Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Avery Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited operates one associated brand: Avery Pharmaceuticals. These brands represent Avery Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
A specialty pharmaceutical company focusing on innovative drug delivery systems and patient care enhancements through Mouth Dissolving Strips technology. averypharma.co.in

Business Activity of Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited is engaged in principal business activities including manufacturing and financial and insurance service, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other financial activities. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
K Financial and insurance Service K8 Other financial activities Locked
Premium access

Business activity turnover details for Avery Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited is audited by R. A. Kuwadia & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
R. A. Kuwadia & Co. Locked Locked Locked
Premium access

Complete auditor history for Avery Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Shilpan Pravin Patel Director 29 May 2017 9 Years 1 Months Current
Neil Shilpan Patel Director 29 May 2017 9 Years 1 Months Current

Financials of Avery Pharmaceuticals Private Limited FY 2025 filings available

Avery Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr (up 42.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.83 Cr ▲ 42.00%
Premium access

Ten-year financial statements for Avery Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Avery Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Avery Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Avery Pharmaceuticals Private Limited

Open charges
₹3 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹3.00 Cr
Latest charge details
DateLenderAmountStatus
30 May 2019 Others ₹3 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited has a workforce of 41 employees as of Mar 29, 2024.

Employee count
41
Active EPFO establishments
1
Employee growth
28.12%
Premium access

Employee and EPFO history for Avery Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Avery Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Avery Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Avery Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Avery Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Avery Pharmaceuticals Private Limited

Premium access

MSME payment history for Avery Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Avery Pharmaceuticals Private Limited

Premium access

Corporate group structure for Avery Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Avery Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Avery Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Avery Pharmaceuticals Private Limited

Activity
30 Sep 2025
Avery Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Avery Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
30 May 2019
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100270587 was registered on 30 May 2019.
Directors
29 May 2017
Shilpan Pravin Patel was appointed as a Director on 29 May 2017 & has been associated with this company since 9 years 1 month.
Directors
29 May 2017
Neil Shilpan Patel was appointed as a Director on 29 May 2017 & has been associated with this company since 9 years 1 month.
Activity
29 May 2017
Avery Pharmaceuticals Private Limited was registered on 29 May 2017 with Roc Mumbai & aged 9 years 1 month as per MCA records.

Recent News on Avery Pharmaceuticals Private Limited

Frequently Asked Questions about Avery Pharmaceuticals Private Limited

Avery Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PTC295476. The company has 41 employees.

Avery Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr for FY 2025 (up 42.00% YoY).

The current directors of Avery Pharmaceuticals Private Limited are:

The primary industry of Avery Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Avery Pharmaceuticals Private Limited can be reached at the registered office: 159 Mittal Industrial Estate Sanjay Building No 5B Marol Naka Andheri E, Mumbai, Maharashtra, India – 400059, or through the website averypharma.co.in.

The authorised capital is ₹1.5 Cr, and the paid-up capital is ₹71.45 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available